Literature DB >> 12957572

Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining.

Anne Letsch1, Carmen Scheibenbogen.   

Abstract

The novel generation of sensitive T-cell assays facilitates the direct quantitation and characterization of specific T-cell responses. Functional T-cell assays such as the ELISPOT assay and the intracellular cytokine cytometry (ICC) employ the antigen-specific induction of cytokines to detect specific T-cells on a single cell level. ICC has the advantage that the simultaneous phenotypic characterization of the antigen-specific T-cells is possible. There is evidence now from clinical cancer vaccination trials, that there is a relationship between the detection of vaccine-induced T-cells by cytokine-based assays and clinical responses. As these assays become increasingly relevant in clinical practice to suggest issues of assay validation and quality control become of major importance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957572     DOI: 10.1016/s1046-2023(03)00124-5

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  26 in total

1.  A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses.

Authors:  Salix Boulet; Michel L Ndongala; Yoav Peretz; Marie-Pierre Boisvert; Mohamed-Rachid Boulassel; Cecile Tremblay; Jean-Pierre Routy; Rafick-P Sekaly; Nicole F Bernard
Journal:  J Immunol Methods       Date:  2006-12-29       Impact factor: 2.303

2.  Evaluation of virus-specific cellular immune response in transplant patients.

Authors:  Cristina Costa; Alda Saldan; Rossana Cavallo
Journal:  World J Virol       Date:  2012-12-12

3.  Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma.

Authors:  Yuan Hong; Yibing Peng; Z Sheng Guo; Jose Guevara-Patino; Junfeng Pang; Lisa H Butterfield; Nahid F Mivechi; David H Munn; David L Bartlett; Yukai He
Journal:  Hepatology       Date:  2014-02-18       Impact factor: 17.425

4.  Development of an IFN-γ ELISpot assay to assess varicella-zoster virus-specific cell-mediated immunity following umbilical cord blood transplantation.

Authors:  Insaf Salem Fourati; Anne-Julie Grenier; Élyse Jolette; Natacha Merindol; Philippe Ovetchkine; Hugo Soudeyns
Journal:  J Vis Exp       Date:  2014-07-09       Impact factor: 1.355

Review 5.  ELISpot for measuring human immune responses to vaccines.

Authors:  Meredith Slota; Jong-Baeck Lim; Yushe Dang; Mary L Disis
Journal:  Expert Rev Vaccines       Date:  2011-03       Impact factor: 5.217

6.  Developing effective tumor vaccines: basis, challenges and perspectives.

Authors:  Qingwen Xu; Weifeng Chen
Journal:  Front Med China       Date:  2007-02-01

7.  Recombinant Salmonella typhimurium outer membrane protein A is recognized by synovial fluid CD8 cells and stimulates synovial fluid mononuclear cells to produce interleukin (IL)-17/IL-23 in patients with reactive arthritis and undifferentiated spondyloarthropathy.

Authors:  S Chaurasia; A K Shasany; A Aggarwal; R Misra
Journal:  Clin Exp Immunol       Date:  2016-05-23       Impact factor: 4.330

8.  Direct Write Protein Patterns for Multiplexed Cytokine Detection from Live Cells Using Electron Beam Lithography.

Authors:  Uland Y Lau; Sina S Saxer; Juneyoung Lee; Erhan Bat; Heather D Maynard
Journal:  ACS Nano       Date:  2015-12-21       Impact factor: 15.881

9.  Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients.

Authors:  Masato Kobayashi; Jin-Sung Chung; Muhammad Beg; Yull Arriaga; Udit Verma; Kevin Courtney; John Mansour; Barbara Haley; Saad Khan; Yutaka Horiuchi; Vijay Ramani; David Harker; Purva Gopal; Farshid Araghizadeh; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  Clin Cancer Res       Date:  2018-07-26       Impact factor: 12.531

10.  Exploring the immunopotentiation of Chinese yam polysaccharide poly(lactic-co-glycolic acid) nanoparticles in an ovalbumin vaccine formulation in vivo.

Authors:  Li Luo; Tao Qin; Yifan Huang; Sisi Zheng; Ruonan Bo; Zhenguang Liu; Jie Xing; Yuanliang Hu; Jiaguo Liu; Deyun Wang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.